Related Experiment Video
Updated: Jul 31, 2026
05:03
Brain Death Induction in Mice Using Intra-Arterial Blood Pressure Monitoring and Ventilation via Tracheostomy
Published on: April 17, 2020
Coma mimicking brain death following baclofen overdose.
M E Ostermann1, B Young, W J Sibbald
1Department of Critical Care, London Health Sciences Centre, Ontario, Canada.
Intensive Care Medicine
|October 13, 2000
Summary
Baclofen toxicity can cause severe coma, but early recognition and supportive care lead to good outcomes. This condition mimics brain death but is treatable with prompt medical intervention.
Area of Science:
- Neurology
- Clinical Toxicology
Background:
- Baclofen overdose can induce profound coma and brainstem dysfunction.
- Diagnosis is primarily clinical, as plasma levels may be unreliable and imaging typically normal.
Observation:
- The case highlights baclofen toxicity presenting with coma and signs mimicking brain death.
- Electroencephalography (EEG) may reveal burst suppression patterns.
Findings:
- Despite the severity, early diagnosis and supportive management are crucial for recovery.
- No specific antidote for baclofen toxicity currently exists.
Implications:
- This emphasizes the importance of considering baclofen toxicity in patients with unexplained coma.
- Prompt recognition and supportive care can significantly improve patient prognosis, even in severe cases.
Related Concept Videos
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...